Speakers
Alison Pottle Consultant Nurse in Cardiology, Harefield Hospital, UK
Jai Cegla Consultant in Chemical Pathology and Metabolic Medicine, Imperial College Healthcare NHS Trust, UK
Learning objectives
-
- To discuss the available tools and potential barriers to screening for FH
- To provide an overview of the recent advances in treatment for dyslipidaemia
- To discuss the role of lipid apheresis in treating people with homozygous FH
- To outline key discussion points to raise with people with dyslipidaemia
Learning module instructions
This BJC TV Learning module has a recommended award of 1 CPD credit for completion (1 hour of learning).
Completion requires a score of at least 80%. If less time is spent learning, then you should claim a reduced credit value.
After you have successfully completed the test you will be able to download your certificate.
References
- NICE (2019) Familial hypercholesterolaemia: identification and management [CG71]. Available at: https://www.nice.org.uk/guidance/cg71 (accessed August 2024)
- Morrell J. Br J Cardiol 2008;15:79–81.
- Public Health England (2018) Familial Hypercholesterolaemia – Implementing a systems approach to detection and management. Available at: https://assets.publishing.service.gov.uk/media/5b646bbced915d37793abcda/familial_hypercholesterolaemia_implementation_guide.pdf (accessed August 2024).
- Benn M et al. Eur Heart J. 2016;37:1384–1394.
- Mach F et al. Eur Heart J. 2020;41:111–188.
